Centiva Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,000
Closed -$504K 1811
2023
Q4
$504K Sell
5,000
-5,000
-50% -$496K 0.01% 954
2023
Q3
$868K Sell
10,000
-18,300
-65% -$1.65M 0.02% 704
2023
Q2
$2.68M Buy
28,300
+5,000
+21% +$422K 0.06% 306
2023
Q1
$1.76M Buy
+23,300
New +$1.76M 0.04% 433
2019
Q2
Sell
-1,500
Closed -$72K 443
2019
Q1
$72K Buy
+1,500
New +$75.1K ﹤0.01% 291

Other funds holding CAH

Centiva Capital's CAH Position: Q2 2026 in Review

Centiva Capital sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 1,583 shares — an estimated $335K sold.

Centiva Capital first reported a position in CAH in Q1 2019 and held it in 17 quarters. The position peaked at $1.86M in Q1 2023. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Centiva Capital reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 1,583 Cardinal Health shares in Q2 2026, an estimated $335K.
  • Centiva Capital first reported a position in Cardinal Health in Q1 2019 and held it in 17 quarters.
  • Centiva Capital's Cardinal Health position peaked at $1.86M in Q1 2023.
  • 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.